Abstract:Heterogeneity of neurodegenerative diseases, including Alzheimer’s disease (AD), has hampered precision diagnosis and prognosis. Machine learning methods are able to dissect neuroanatomical heterogeneity and enable identification of disease subtypes via their imaging signatures. We apply a novel semi‐supervised deep‐learning clustering method to derive dimensions of neurodegeneration, and investigate longitudinal paths in this dimensional system. Analyses used structural MRIs (from the Alzheimer’s Disease Neuroimaging Initiative and the Baltimore Longitudinal Study of Aging; total 2,832 participants; 8,146 scans) including controls and patients with Mild Cognitive Impairment (MCI) and AD. Smile‐GAN identified 4 neurodegenerative patterns/axes (Figure 1): P1, normal anatomy; P2, mild/diffuse atrophy; P3, focal medial temporal atrophy; P4, advanced neurodegeneration. Further application to longitudinal data revealed two distinct progression pathways: P1→P2→P4 and P1→P3→P4. Clinically, P2 participants showed worse performance in executive function than P3 participants (median ADNI‐EF= ‐0.29 vs. ‐0.1, with p=0.038) but had better memory (ADNI‐MEM= ‐0.13 vs. ‐0.39, with p=0.003) (Figure 2). Progression to P4 occurred more rapidly from P3 than P2, with median survival time to progression of 4.5 years and 3.2 years for P2 and P3 MCI/Dementia participants, respectively. Baseline expression of these patterns predicted the pathway and rate of future neurodegeneration, with high accuracy for determining whether P1 participants would progress and whether they would progress to P2 or P3 (Cox‐proportional‐hazard model average concordance index (CI) on the validation set of 0.8±0.02). Pattern expression offered better performance (CI=0.72±0.02) in predicting clinical conversion from MCI to Dementia compared to amyloid/tau (CI=0.69±0.02), with all three together showing modest improvement over pattern performance (CI=0.76±0.02). A composite risk score comprised of pattern probabilities, Abeta, pTau, presence of APOE E4, and ADAS‐cog score was able to predict survival time with an average concordance index, 0.78±0.02 on randomly split validation sets. (Figure 3). Four reproducible volumetric patterns, and 2 major longitudinal pathways were revealed using deep learning, which can be determined on an individual patient basis and has implications for rate of future decline. These pattern‐based biomarkers can enrich the N‐dimension of the A/T/N framework which may inform on clinical trial enrollment and monitoring outcomes in a more personalized manner.

Delineating the Heterogeneity of Alzheimer's Disease and Mild Cognitive Impairment Using Normative Models of Dynamic Brain Functional Networks.

Topological Properties Analysis and Identification of Mild Cognitive Impairment Based on Individual Morphological Brain Network Connectome.

Resolving heterogeneity in Alzheimer's disease based on individualized structural covariance network

Four Distinct Subtypes of Alzheimer’s Disease Based on Resting-State Connectivity Biomarkers

Four distinct subtypes of Alzheimer's disease based on resting-state connectivity biomarkers

Analyzing heterogeneity in Alzheimer Disease using multimodal normative modeling on imaging-based ATN biomarkers

Alteration of Functional Connectivity Network in Population of Objectively-Defined Subtle Cognitive Decline.

Characterizing the clinical heterogeneity of early symptomatic Alzheimer's disease: a data-driven machine learning approach

Molecular Subtyping of Mild Cognitive Impairment Based on Genetic Polymorphism and Gene Expression

Distinct profiles of functional connectivity density aberrance in Alzheimer's disease and mild cognitive impairment

Grab‐AD: Generalizability and Reproducibility of Altered Brain Activity and Diagnostic Classification in Alzheimer's Disease

Heterogeneity of Regional Brain Atrophy Patterns Associated with Distinct Progression Rates in Alzheimer’s Disease

Altered Weibull degree distribution in resting‐state functional brain networks in Alzheimer’s disease: Neuroimaging / Optimal neuroimaging measures for early detection

Machine Learning Decomposition of the Anatomy of Neuropsychological Deficit in Alzheimer's Disease and Mild Cognitive Impairment.

Identification of mild cognitive impairment subtypes predicting conversion to Alzheimer's disease using multimodal data

Disentangling brain heterogeneity via semi‐supervised deep‐learning and MRI: Application to dimensional representations of Alzheimer’s disease

Aberrant Intra- and Inter-Network Connectivity Architectures in Alzheimer’s Disease and Mild Cognitive Impairment

Investigation on the Alteration of Brain Functional Network and Its Role in the Identification of Mild Cognitive Impairment

Reorganized brain functional network topology in stable and progressive mild cognitive impairment

Abnormal Dynamic Functional Networks in Subjective Cognitive Decline and Alzheimer's Disease

Uncovering Heterogeneous Cognitive Trajectories in Mild Cognitive Impairment: a Data-Driven Approach